Clinical Memory Research
1101 – 1150 of 1268
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cystatin C Levels are Positively Correlated with both A beta(42) and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
(
- Contribution to journal › Article
-
Mark
alpha-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases
(
- Contribution to journal › Article
-
Mark
Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment.
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta(40) and A beta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
F-18-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
(
- Contribution to journal › Article
-
Mark
Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls
(
- Contribution to journal › Article
-
Mark
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract
(
- Contribution to journal › Article
-
Mark
Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain
(
- Contribution to journal › Article
-
Mark
Lack of Accuracy for the Proposed 'Dubois Criteria' in Alzheimer's Disease: A Validation Study from the Swedish Brain Power Initiative
(
- Contribution to journal › Article
-
Mark
No Association of VEGF Polymorphims with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Evaluation of plasma A beta 40 and A beta 42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment Response
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
(
- Contribution to journal › Article
-
Mark
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
(
- Contribution to journal › Article
-
Mark
Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
(
- Contribution to journal › Article
-
Mark
Plasma concentration of galantamine - influence of dose and body mass index in Alzheimer’s disease.
2010) 11th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy(
- Contribution to conference › Poster
-
Mark
A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
(
- Contribution to journal › Article
-
Mark
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Association of the RAGE G82S polymorphism with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
(
- Contribution to journal › Article
-
Mark
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
An enzyme activity as a potential biomarker for Alzheimer's disease.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.497-498(
- Contribution to journal › Published meeting abstract
-
Mark
Convergence of chromogranin and amyloid metabolism in the brain.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.511-511(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
EVOLUTION OF A beta 42 AND A beta 40 LEVELS AND A beta 42/A beta 40 RATIO IN PLASMA DURING PROGRESSION OF ALZHEIMER'S DISEASE: A MULTICENTER ASSESSMENT
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Long-term rivastigmine treatment in a routine clinical setting.
(
- Contribution to journal › Article
-
Mark
Neurodegenerative Biomarkers in Healthy Elderly - with special reference to the preclinical pattern of biological and cognitive markers for Alzheimer’s disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil
(
- Contribution to journal › Article
-
Mark
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk
(
- Contribution to journal › Article
-
Mark
Concentrations of Metals, beta-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Total Tau Is Associated with Shorter Survival in Dementia with Lewy Bodies.
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
(
- Contribution to journal › Article
-
Mark
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity.
(
- Contribution to journal › Article
-
Mark
Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests.
(
- Contribution to journal › Article
-
Mark
Risk Factors for Nursing Home Placement in Cholinesterase Inhibitor Treated Naturalistic Alzheimer Patients.
2009) 9th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD)(
- Contribution to conference › Poster
-
Mark
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
(
- Contribution to journal › Article
-
Mark
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
(
- Contribution to journal › Article
-
Mark
Lewykroppsdemens - stor risk för felbehandling och död
(
- Contribution to journal › Article
-
Mark
Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
2009) 13th Congress of the European-Federation-of-Neurological-Societies In European Journal of Neurology 16(Suppl 3). p.337-337(
- Contribution to journal › Published meeting abstract
-
Mark
Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Dementia with Lewy bodies —an Investigation of Cause and Consequence
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Medial Temporal Lobe Atrophy Increases the Specificity of Cerebrospinal Fluid Biomarkers in Alzheimer Disease with Minor Cerebrovascular Changes.
(
- Contribution to journal › Article
-
Mark
The PPAR-alpha gene in Alzheimer's disease: Lack of replication of earlier association
(
- Contribution to journal › Article
-
Mark
NMDA receptor stimulation induces reversible fission of the neuronal endoplasmic reticulum.
(
- Contribution to journal › Article